GILEAD SCIENCES NORWAY AS
991461841ActiveDeveloping transformative medicines for life-threatening diseases globally.
Pharmaceutical and Biotechnology Companygilead.com
Yleiskatsaus
- 5
- Työntekijät
- 186.2milj NOK
- Liikevaihto
- 2007
- Perustettu
Avainpäättäjät
Stacey Ma
Executive Vice President, Pharmaceutical Development and Manufacturing
Daniel O’Day
Chairman and Chief Executive Officer
Andrew Dickinson
Chief Financial Officer
Jyoti Mehra
Executive Vice President, Human Resources
+6 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Gilead Sciences is a research-based biopharmaceutical company dedicated to discovering, developing, and delivering innovative therapeutics for people with life-threatening diseases. The organization focuses its scientific rigor on three primary therapeutic areas: virology, oncology, and inflammation...
GlaxoSmithKline Aktiebolag